ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,420, issued on Oct. 21, was assigned to GBIOLOGICS INC. (Seongnam-si, South Korea).
"Pharmaceutical composition, comprising recombinant stabilized galectin 9 protein, for prevention or treatment of rheumatoid arthritis and bone disease" was invented by Dong Ho Song (Seongnam-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a recombinant stabilized galectin 9 protein and the use thereof, and more specifically, relates to a pharmaceutical composition comprising the recombinant stabilized galectin 9 protein for prevention or treatment of rheumatoid arthritis and a bone disease. The recombinant stabilized g...